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Abstract
Background: In men, hypovitaminosis D as well as high and low testosterone levels have been linked to
adverse events, including death. A biological interaction has been previously suggested between vitamin D
and androgens. In a cohort study using Third National Health and Nutrition Examination Survey data, we
simultaneously investigated circulating vitamin D and biomarkers of sex steroid hormones as predictors of
all-cause mortality.
Methods: Age-adjusted and fully-adjusted Cox regression models were constructed to estimate hazard
ratios (HR) and their 95% confidence intervals (CI). Whereas the vitamin D sufficient group (25(OH)D3≥30
ng/ml) was selected as a referent, biomarkers of sex steroid hormones (testosterone, estradiol, SHBG) were
defined as Loge-transformed continuous variables.
Results: Of 1,472 men with a mean age of 42.1 years at baseline, 382 died over a median of 192 months
of follow-up. Estradiol levels were significantly higher among vitamin D deficient compared to vitamin
D sufficient men and sex hormone binding globulin level was significantly higher in vitamin D sufficient
compared to vitamin D insufficient or deficient groups. An inverse non-linear relationship was observed
between all-cause mortality rate and levels of testosterone, estradiol and vitamin D, in fully-adjusted
models. There were no significant interaction effects between vitamin D and sex steroid hormones in
relation to all-cause mortality rate.
Conclusions: Vitamin D and sex steroid hormones, but not sex hormone binding globulin, may be inversely
and non-linearly related to all-cause mortality among adult men, after adjustment for baseline demographic,
socioeconomic, lifestyle and clinical characteristics.
Keywords: All-cause mortality, androgens; cohort study, estradiol, sex hormone binding globulin,
testosterone, vitamin D

Introduction

autoimmune diseases, type 2 diabetes, cardiovascular disease
In men, hypovitaminosis D as well as both high or low testos- [6,7] and all-cause mortality [5]. The main source of vitamin D
terone levels have been linked to adverse events, including is cholecalciferol (vitamin D3), synthesized in the skin by ultradeath. Vitamin D is a fat-soluble secosteroid hormone endowed violet radiation [2]; pro-vitamin D3 (7-dehydrocholesterol) is
with pleiotropic effects [1,2]. Besides the well-known function converted to pre-vitamin D3, which isomerizes into cholecalof vitamin D in promoting in vitro bone mineralization and ciferol and is later converted to calcitriol (1,25(OH)2D3) through
prevention of osteoporosis and bone fracture through intes- a two-step enzymatic pathway involving liver 25-hydroxylase
tinal calcium absorption [3,4], mounting evidence has linked (CYP2R1) andkidney 1-α-hydroxylase (CYP27B1) [2,8,9]. Vitamin
hypovitaminosis D to musculoskeletal diseases [5], cancer [6], D status is assessed by measuring 25(OH)D3 [8]. Currently, the
© 2015 Beydoun et al; licensee Herbert Publications Ltd. This is an Open Access article distributed under the terms of Creative Commons Attribution License
(http://creativecommons.org/licenses/by/3.0). This permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
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Institute of Medicine advises 25(OH)D3 ≥20 ng/ml but Endocrine Society advises 25(OH)D3 ≥30 ng/ml, partly due to lack of
adequate assays for vitamin D quantification; thus, individuals
are considered sufficient if 25(OH)D3≥30 ng/ml (≥74 nmol/L),
insufficient if 25(OH)D3 is 20-29 ng/ml (50-74 nmol/L), and
deficient if 25(OH)D3<20 ng/ml (<50 nmol/L) [5,7]. A biological interaction has been previously suggested between
vitamin D and androgens [5,10-12]. Specifically, androgens
may increase 1-α-hydroxylase, a key enzyme in vitamin D
metabolism, and regulation of gene expression by vitamin
D metabolites is modified according to androgen levels [5].
Numerous biological mechanisms have been proposed in an
effort to explain the joint protective effects of vitamin D and
sex steroids on bone fracture which is generally less among
males compared to females [12], while other studies have suggested a contribution for testicular vitamin D metabolism [11].
The key androgen, in men,is testosterone, 50-60% of which
is bound with high affinity to sex hormone binding globulin
(SHBG), and the remaining 40-50% is bound loosely to albumin and other proteins, leaving 1-3% as ‘free’ testosterone
[13]. The clinical significance of testosterone level in men
remains controversial [5,14,15], with low and high levels of
testosterone linked to deleteriousoutcomes [16]. Starting
in the 3rd-4th decade of life, male aging is accompanied by
0.4-2.6% annual decline in total testosterone and 0.2% annual decline in ‘free’ testosterone resulting from gradual rise
in SHBG, implying a clinical significance for measuring‘free’
testosterone [5,17,18]. Age-related decline in endogenous
testosterone, or male hypogonadism, has been associated
with reduced libido and vitality, depression, sarcopenia, obesity, dyslipidemia, hypertension, metabolic syndrome, type
2 diabetes, stroke, atherosclerosis, subclinical inflammation,
osteoporosis, trauma fracture and mortality risk [13,16,19-21];
an increasing level of SHBG, which predominantly carries
testosterone and estradiol in the blood, has also been associated with cardiovascular risk factors andhigher risk for
premature death [22]. Similarly, when administered at high
doses, exogenous testosterone has been correlated with
sudden cardiac death and liver disease [16,23,24]. However,
perceived health benefits of low dose exogenous testosterone
may have contributed to its widespread use without approved
change in indication [16,22,25-27].
The purpose of this population-based cohort study is to
simultaneously investigate vitamin D and biomarkers of sex
steroid hormones (testosterone, estradiol, SHBG as predictors
of all-cause mortality among adult men in the Third National
Health and Nutrition Examination Survey (NHANES III).

Methods

Study population

doi: 10.7243/2052-8000-3-1
naire, physical examination and laboratory data from Phase I
of NHANES III. Public-use datasets, including adult (n=20,050),
exam (n=31,311), examdr (n=30,818), lab (n=29,314), lab2
(n=29,314), nhanes3 (n=33,994) and sshormon (n=1,636)
were merged to select male adults (18 years and older) with
serum specimens analyzed for vitamin D, biomarkers of sex
steroid hormones and all-cause mortality data. A total of 1,472
NHANES III participants were included in the study. NHANES
III is compliant with ethical rules of human experimentation
stated in the Declaration of Helsinki, including approval by
institutional review board and informed consent.

Measures
All-cause mortality

Mortality linkage of NHANES III with the National Death Index
provides the opportunity to investigate associations of a wide
range of characteristics at baseline with mortality rates at
follow-up through December 31, 2006. Variables provided
in this linked mortality file include sequence number, eligibility status, assigned vital status, mortality source, personmonths of follow-up from interview date, person-months of
follow-up from Mobile Examination Center (MEC) or home
examination date and underlying multiple causes of death
[29]. In this analysis, an event was defined as death from any
cause during the follow-up period, starting at date of MEC
examination and ending before December 31, 2006. Sensitivity analyses were performed to examine shorter durations (5
years and 10 years) of follow-up, yielding similar results to the
total follow-up period.

Vitamin D

Serum 25(OH)D3 concentration was determined in ng/mL
(range: 5-160.3 ng/mL; limit of detection is 3.5 ng/mL) and
nmol/L (range: 12.5-400.1 nmol/L; limit of detection is 8.7
nmol/L) at the National Center for Environmental health using DiaSorin radioimmunoassay kit (Stillwater, MN) [30,31].
NHANES documentation did not include inter- or intra-assay
coefficients of variation for vitamin D. Because of skewed
distribution, vitamin D concentration was loge-transformed
or defined as a categorical variable (Deficient: <20 ng/ml;
Insufficient: 20-<30 ng/ml; Sufficient: ≥30 ng/ml), taking the
sufficient group as a referent.

Biomarkers of sex steroids

Serum testosterone, estradiol and SHBG concentrations were
quantitatively determined using immunoassay techniques.
NHANES documentation did not include inter-assay and
intra-assay coefficients of variation for sex steroid hormones.
Because of skewed distributions, loge-transformation and
categorization in quintiles were performed for biomarkers
of sex steroid hormones.

The National Center for Health Statistics implemented
NHANES III between 1988 and 1994 in two phases (Phase I:
1988-1991, Phase II: 1991-1994) using a complex multistage Testosterone
probability sample design [28]. This study utilized question- Elecsys Testosterone was used to measure circulating testos-
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terone concentration and was based on a competitive test
principle using a monoclonal antibody directed against testosterone. The measuring range for testosterone is 0.069-52.00
nmol/L or 0.020-15.00 ng/mL, with a lower detection limit of
0.069 nmol/L (0.02 ng/mL) and a functional sensitivity (level
at which between-run coefficient of variation is less than or
equal to 20%) of 0.42 nmol/L (0.12 ng/mL) [32].

were used for comparing loge-transformed testosterone,
estradiol and sex hormone-binding globulin concentrations across vitamin D status groups.Kaplan-Meier curves
were constructed and log-rank tests were used to examine
bivariate relationships between exposure variables (defined
in quintiles) and survival. For multivariable analyses, hazard
ratios (HR) and their 95% confidence intervals (CI) were calculated using Cox regression models. Fully-adjusted models
Estradiol
were controlled for age (continuous), race/ethnicity, smokElecsys Estradiol II was used to measure circulating estradiol ing status, and physical activity (categorical). Furthermore,
concentration and employs a competitive test principle using a we examined non-linearity by including quadratic terms for
polyclonal antibody specifically directed against 17β-estradiol. exposure variables and evaluated the interaction between
The measuring range for estradiol is 18.4-15,781 pmol/L (5.00- vitamin D status and biomarkers of sex steroid hormones in
4,300 pg/mL), with a lower detection limit of 18.4 pmol/L (5.0 age-adjusted and fully-adjusted models. Several aspects of
pg/mL) and a functional sensitivity (level at which between- NHANES III design were taken into account in data analyses,
run coefficient of variation is less than or equal to 20%) of 44 including sampling weights and complex survey design
pmol/L (12 pg/mL) [33].
(primary sampling unit (PSU) and strata). Three full-sample
and four sub-sample weights are available in NHANES III. For
Sex hormone binding globulin
this analysis, we applied the MECweights with strata and PSU
Elecsys SHBG is used to measure SHBG concentration and based on Phases I of NHANES III (i.e., 3 years). Sampling weights
employs two monoclonal antibodies specifically directed were used to correctly estimate population prevalence rates,
against it. The measuring range for SHBG is 0.350-200 nmol/L, means and other statistics while accounting for differential
with a lower detection limit of 0.35 nmol/L [34].
probabilities of selection, non-coverage, non-response and
over-sampling of sub-populations. Two-sided statistical tests
Demographic, socioeconomic, lifestyle and clinical were performed at alpha of 0.05.

characteristics

Age (continuous; ‘18-20’, ‘20-39’, ‘40-59’, ‘60+’ years), education
(‘Less than High School’, ‘High School’, ‘More than High School’),
race/ethnicity (‘Non-Hispanic White’, ‘Non-Hispanic Black’,
‘Hispanic’, ‘Other’), area of residence (‘Metropolitan’, ‘Other’),
poverty income ratio (continuous; ‘<100%’, ‘100%-<200%’,
‘≥200%’), marital status (‘Married/Co-habiting’, ‘Not married’),
smoking status (‘Current smoker’, ‘Ex-smoker’, ‘Never smoker’),
alcohol consumption (at least 12 glasses in the past 12 months)
(‘yes’, ‘no’), body mass index (BMI) based on directly measured
weight and height (continuous; ‘<25’, ’25-<30’, ‘30+’ kg/m2),
waist-to-hip ratio defined as ratio of directly measured waist
and hip circumferences (continuous; ‘≤0.9’, ‘>0.9’), self-rated
health (‘excellent’, ‘very good’, ‘good’, ‘fair’, ‘poor’), history of
chronic conditions including arthritis, asthma, chronic bronchitis, emphysema, congestive heart failure, stroke, diabetes
and cancer (‘yes’, ‘no’), and physical activity (continuous; ‘0’,
‘>0-<100 METS’, ‘100-<200 METS’, ‘200-<300 METS’, ‘≥300 METS’).

Results

Table 1 describes baseline demographic, socioeconomic, life-

style and clinical characteristics of study participants. Of 1,472
men with (mean±SEM) age of (42.1±0.6) years at baseline, 77%
were non-Hispanic White, 70% were married or cohabiting,
47% had more than high school education and nearly 10%
were below the PIR. Whereas 35% were never smokers and
71% drank alcohol in the past 12 months, 18% were obese,
71% exhibiting central obesity, 13% reported fair or poor
self-rated healthand 28% reported having major chronic
conditions,and physical activity was, on average, 139.3±8.2
METS. Descriptive statistics for vitamin D and biomarkers of
sex steroid hormones are also presented in Table 1.
Vitamin D was weakly correlated with biomarkers of sex
steroid hormones including testosterone (rspearman =0.08),
estradiol (r spearman=-0.07) and SHBG (r spearman=0.09). When
loge-transformed testosterone, estradiol and SHBG, were
compared among vitamin D sufficient, insufficient and defiStatistical analysis
cient men, estradiol levels were significantly higher among
Statistical analyses were performed using STATA version 12 vitamin D deficient compared to vitamin D sufficient men and
(STATA Corporation, College Station, TX). Whereas frequencies sex hormone binding globulin level was significantly higher
and percentages were computed for categorical variables, for in vitamin D sufficient compared to vitamin D insufficient or
continuous variables mean, median, standard deviation (SD), deficient groups (Table 2).
standard errors of the mean (SEM) and inter-quartile ranges
A total of382 men died over a median of192 months with
were computed, as appropriate. Shapiro-Wilk’s normality an interquartile range of 183 to 202 months of follow-up
test was applied and continuous exposure variables were (<5 years:100; 5-<10 years:105; ≥10 years:1,267), for an estiloge-transformed, as needed. One-way ANOVA tests with mated all-cause mortality rate of 16.7% (95%CI:14.8%-18.8%).
post-hoc comparisons evaluated using Bonferronicorrections Kaplan-Meier curves were constructed to examineall-cause
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Table 1. Demographic, socioeconomic, lifestyle and
clinical characteristics in adult men in the study
sample (n=1472)–Third National Health and Nutrition
Examination Survey.
Characteristic
N
Age (years):
Mean±SEM
<20
20-39
40-59
60+
Race / Ethnicity:
Non-Hispanic White
Non-Hispanic Black
Mexican-American
Other
Marital status:
Married / Cohabiting
Not Married
Education:
Less than High School
High School
More than High School
Poverty-Income Ratio:
Mean±SEM
<100%
100%-<200%
≥200%
Unknown
Urban-Rural Residence:
Metropolitan
Other
Smoking status:
Current smoker
Ex-smoker
Never smoker
Alcohol use – past 12 months:
Yes
No
Unknown
Body Mass Index (kg/m2):
Mean±SEM
<25
25-<30
≥30
Waist-to-Hip Ratio:
≤0.9
>0.9
Self-Rated Health:
Excellent
Very Good

Mean±SEM or %
1472
42.1±0.6
3.1
47.5
31.5
17.9
77.4
9.9
5.1
7.4
69.6
30.4
23.6
29.2
47.2
3.1±0.1
9.8
17.4
65.6
7.2
45.1
54.9
33.2
31.4
35.4
Mean±SEM or %
70.8
21.7
7.5
26.7 ± 0.4
44.9
36.7
18.3
29.4
70.6
25.5
29.9

doi: 10.7243/2052-8000-3-1
Continuation of Table 1.
Good
30.5
Fair
11.3
Poor
2.7
History of Major Chronic Conditions *:
Yes
28.4
No
71.6
Physical Activity (Metabolic Equivalents):
Mean±SEM
139.3±8.2
0
8.4
>0-<100
41.5
100-<200
25.9
200-<300
11.3
≥300
12.8
Vitamin D (ng/ml)
Median [IQR]
Sufficient (≥ 30)
Insufficient (20-<30)
Deficient (<20)
Testosterone (ng/mL):
Median [IQR]
Estradiol (pg/mL):
Median [IQR]
Sex hormone-binding
globulin (nmol/L):
Median [IQR]

Mean±SEM or %
26.7 [20.2-34.3]
50.3
33.1
16.5
5.4±0.15.15
[3.97-6.56]
37.2±0.735.4
[29.5-43.7]
37.9±0.836.1
[25.9-49.7]

* Major chronic conditions include self-reported
physician diagnosis of arthritis, asthma, chronic
bronchitis, congestive heart failure, diabetes,
emphysema, stroke, skin cancer and other cancer.

mortality across quintiles of testosterone, estradiol and SHBG,
and according to vitamin D status. Log-rank tests suggested
statistically significant crude differences (P<0.0001) in survival
according quintiles of testosterone and SHBG, but not according to estradiol level or vitamin D status (Figures 1A-1D).
Table 3 presents Cox regression models for circulating vitamin D (loge-transformed and categorical) and biomarkers
of sex steroid hormones (loge-transformed) as predictors of
all-cause mortality, while examining linearity and interaction
effects. Vitamin D deficiency but not insufficiency was significantly related to all-cause mortality in age-adjusted but not in
fully-adjusted models. By contrast, loge-transformed vitamin
D concentration and biomarkers of sex steroid hormones did
not exhibit a linear relationship to all-cause mortality rate in
either age-adjusted or fully-adjusted models. By including
quadratic terms, we observed an inverse non-linear relationship
between all-cause mortality rate and levels of testosterone,
estradiol and vitamin D, in fully-adjusted models. Furthermore,
there were no significant interaction effects between vitamin
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Table 2. Circulating Biomarkers of Sex Steroid Hormones
Concentrations among Vitamin D Sufficient, Insufficient and
Deficient Adult Men in the Study Sample (n=1472)-Third
National Health and Nutrition Examination Survey.
Mean±SD

Vitamin D status
Group 1 Group 2
Group 3
Sufficient Insufficient Deficient

Testosterone
(ng/mL)

5.5±2.1

5.2±1.9

Estradiol
(pg/mL)

36.8±13.3 36.9±11.0

Sex hormone42.9±21.6 38.1±17.9
binding globulin
(nmol/L)

P-value *
2 vs. 1
3 vs. 1
2 vs. 3
5.1±2.0
0.1ns
0.03ns
0.4ns
38.9±13.4 0.6ns
0.006sign
0.02ns
39.2±20.3 <0.0001sign
0.003sign

* P values are determined based on one-way ANOVA tests for
comparing loge-transformed testosterone, estradiol, sex hormonebinding globulin concentrations across vitamin D status groups.

D and sex steroid hormones in relation to all-cause mortality rate. We found no significant interaction effects between
age group and the selected exposure variables; therefore, no
stratified analyses were performed according to age group
(data not shown).

Discussion

In a population-based cohort study, we examined vitamin
D and biomarkers of sex steroid hormones–separately and
simultaneously–as predictors of all-cause mortality among
adult men, 18 years and older, who participated in NHANES III.
Significant differences in estradiol and SHBG concentrations
were found across levels of vitamin D status. In age-adjusted
but not fully-adjusted models, vitamin D deficiency was positively linked to all-cause mortality. Loge-transformed levels
of vitamin D, testosterone and estradiol were non-linearly
but inversely related to all-cause mortality, independently of
baseline demographic, socioeconomic, lifestyle and clinical
characteristics. There were no statistically significant interactions between vitamin D and biomarkers of sex steroid
hormones in relation to all-cause mortality in age- or fully
adjusted models.
Previously, Sempos and colleagues who analyzed the
complete cohort of 15,099 NHANES III participants aged
≥20 years with 3,784 deaths reported over a 9-year followup period (1991-2000) found a reverse J-shaped association
between serum vitamin D and all-cause mortality [35]. In
another study of 1,114 NHANES III participants followed-up
for a period of 18 years, differences in all-cause mortality
were noticed between 90th and 10th percentiles of the sex
hormone levels, including free and bioavailable testosterone
[36]. Discrepancies between these studies and ours may be
due to differences in exposure assessment and ability to detect

doi: 10.7243/2052-8000-3-1
Table 3. Cox proportional hazards models for Circulating
Vitamin D and Loge-transformed Biomarkers of Sex Steroid
Hormone Concentrations as predictors of Age-Adjusted and
Fully-Adjusted All-Cause Mortality Rate among Adult Men in
the Study Sample (n=1472)–Third National Health and Nutrition
Examination Survey.
Age-Adjusted

Fully-Adjusted

Overall

HR

95%CI

HR

95%CI

Testosterone
Estradiol
Sex hormone binding
globulin:
Vitamin D-continuous

1.08
1.53
1.42

0.82-1.43
0.87-2.70
0.79-2.54

0.92
1.06
1.23

0.70-1.22
0.61-1.81
0.70-2.17

0.84

0.61-1.17

0.99

0.66-1.48

Sufficient Vitamin D
Insufficient Vitamin D
Deficient Vitamin D
Linearity

Ref.
0.97
1.47
HR

-0.69-1.35
1.04-2.08
95%CI

Ref.
0.92
1.33
HR

-0.65-1.29
0.88-2.01
95%CI

Testosterone
Testosterone2
Estradiol
Estradiol2
Sex hormone binding
globulin
Sex hormone binding
globulin2
Vitamin D
Vitamin D2
Interactions

0.89
1.22
0.08
1.53
0.07

0.76-1.04
1.08-1.40
0.01-0.54
1.13-2.05
0.003-1.63

0.79
1.19
0.05
1.11
0.24

0.66-0.96
1.03-1.38
0.004-0.76
1.09-1.12
0.041-3.89

1.50

0.98-2.31

1.25

0.84-1.86

0.003
2.33
HR

0.0002-0.07 0.01
1.46-3.72
2.00
95%CI
HR

0.0004-0.29
1.98-3.36
95%CI

Testosterone
Insufficient Vitamin D
Deficient Vitamin D
Testosterone*Insufficient
Vitamin D
Testosterone*Deficient
Vitamin D
Estradiol
Insufficient Vitamin D

1.13
1.04
1.67
0.96

0.75-1.71
0.43-2.54
0.49-2.54
0.51-1.79

1.00
1.08
1.79
0.90

0.63-1.61
0.47-2.52
0.58-5.54
0.48-1.68

0.91

0.39-2.14

0.80

0.37-1.73

1.94
4.09

Deficient Vitamin D

14.80

Estradiol*Insufficient
Vitamin D
Estradiol*Deficient
Vitamin D
SHBG

0.66

0.71-5.31
0.030660.10
0.073342.88
0.16-2.70

1.53 0.52-4.49
10.59 0.0591876.57
14.12 0.044989.95
0.50 0.12-2.09

0.52

0.12-2.33

0.51

0.10-2.56

1.41

0.67-2.94

1.26

0.62-2.54

Insufficient Vitamin D

1.21

0.02-75.17

1.20

0.03-43.7

Deficient Vitamin D

0.62

0.017-23.04 0.99

0.05-20.9

SHBG*Insufficient
Vitamin D
SHBG*Deficient
Vitamin D

0.95

0.32-2.88

0.94

0.35-2.49

1.26

0.49-3.29

1.09

0.48-2.44

Vitamin D–categorical:

Fully-Adjusted Cox proportional hazards models included age, race/
ethnicity, smoking status and physical activity.
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(A)

(C)

(B)

(D)

Figure 1. Kaplan-Meir curve for all-cause mortality according to.
(A) Testosterone quintiles (B) Estradiol quintiles (C) Sex hormone binding globulin quintiles (D) Vitamin D status.

small risk changes among groups. For instance, we defined
testosterone as loge-transformed variables or in quintiles (taking the 3rd quintile as a referent) and our sample consisted of
NHANES III participants with data available on vitamin D and
biomarkers of sex steroid hormones [35,36].
To our knowledge, this epidemiological study is one of few
to have simultaneously examined vitamin D, biomarkers of
sex steroid hormones and all-cause mortality and the first
to assess these associations using a nationally representative sample. Our study findings pertaining to vitamin D and
biomarkers of sex steroid hormones as predictors of all-cause
mortality are somewhat consistent with two previous studies
[36,37]. In a large cohort of coronary angiography patients,
Lerchbaum and colleagues observed that vitamin D and free
T deficient men experienced the highest risk for all-cause
mortality even after multivariable adjustment. Moreover, in
men with vitamin D deficiency, low free T levels were associated with fatal events, whereas no association of free T with
fatal events was found in men with vitamin D insufficiency
or sufficiency [5]. In another study of 782 French men ≥50
years, Szulc and colleagues identified the lowest quartile of

vitamin D as predictor of mortality (HR=1.44, 95% CI: 1.032.03); estradiol level predicted mortality after the third year
(HR=1.21 per 1 SD increase, 95% CI: 1.09-1.35), where by risk
of death increased per quartiles of estradiol level and was
higher in third and fourth quartiles compared with the lowest quartile (HR=1.80, 95% CI: 1.09-2.98 and HR=2.83, 95% CI:
1.71-4.67); mortality risk was not significantly associated with
testosterone level [37]. Unlike the present study,no formal
testing for interaction between vitamin D and biomarkers of
sex steroid hormones was performed in these studies [36,37].
Whereas the link between vitamin D deficiency and allcause mortality is well-established [38-41], the current
epidemiological evidence linking endogenous total and
free testosterone concentrations to mortality risk among
men remains inconclusive. While total testosterone was
mostly negatively related to mortality [13,14,16,20,42] with
one study reporting a non-significant relationship [22], free
testosterone was positively [22] or negatively [5] related to
mortality andlimited evidence suggests that SHBG may not
be related [22] to mortality.
The finding that testosterone levelswere negatively and
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non-linearly related to all-cause mortality in fully-adjusted
models is in line with the idea that as men age they experience
a decline in testosterone [17,43], and is in line with another
study [43]. In a case-cohort study of 495 elderly men (146 with
ischemic arterial disease (IAD) and 349 controls), a J-shaped
association was observed between total testosterone and
IAD risk, whereby HR in the lowest and the highest quintiles
relative to the second quintile were 2.23 (95% CI: 1.02; 4.88)
and 3.61 (95% CI: 1.55; 8.45), respectively [43]. A similar Jshaped relationship was observed between IAD risk and free
T, whereas SHBG was not significantly related to IAD risk [43].
The absence of a significant relationship between SHBG and
all-cause mortality may be explained by the complex relationship among factors that determine SHBG level. Whereas the
process of aging is accompanied by a rise in SHBG level, it is
also accompanied by a rise in cardiovascular risk factors, such
as obesity, insulin resistance, type 2 diabetes, hypertension,
dyslipidemia and inflammation, which, in turn, are negatively
correlated with SHBG level [17].
Our results should be interpreted with caution and in light of
several limitations. First, the study design is observational and
although cohort studies are considered as the gold standard
in epidemiology, cause-and-effect relationships cannot be
clearly established. Second, sex steroid hormones are known
to vary on a diurnal basis, and the use of a single measurement for each of these biomarkers could potentially lead to
non-differential misclassification bias. In addition, sex steroid
hormones were measured by immunoassays and vitamin D
was measured using DiaSorin(rather than mass spectrometry) which are now widely understood to be suboptimal for
clinical research involving women, children or men with low
serum testosterone [44,45] and especially for serum estradiol
in men [46,47]. However, previous studies have indicated an
association between testosterone levels and adverse events,
irrespective of whether immunoassays or mass-spectrometry
measurements were applied [5,14,15]. Third, the present study
examined testosterone and SHBG levels but did not examine
measures of free or bioavailable testosterone.Further analyses
should be performed whereby ‘free’ testosterone is calculated
using validated equations [48,49]. Fourth, sample size limitations may have precluded our ability to identify significant
interactions between vitamin D and biomarkers of sex steroid
hormones. Also, complete-subject analyses based on availability of data on key variables of interest may have resulted
in selection bias. Fifth, the role of chance cannot be ruled out
given the large number of statistical tests being conducted.
Sixth, although numerous covariates were included in the
multivariate models, residual confounding cannot be ruled
out as an explanation for the observed associations. For instance, total caloric intake was measured using 24-hour recall
which may be inadequate as an assessment of usual food
consumption. Finally, our findings can only be generalized
to adult men, and further research is needed to evaluate the
role of sex steroid hormones in women as well as individuals
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at different stages of life.

Conclusion

Vitamin D, testosterone and estradiol, but not sex hormone
binding globulin, may be inversely and non-linearly related
to all-cause mortality among adult men, after adjustment
for baseline characteristics. Future studies should attempt to
elucidate the complex relationships of circulating vitamin D
with sex steroid hormones and their impact on health-related
outcomesamong men. In particular, studies should assess the
potentially mediating role of vitamin D in the relationship
between circulating sex steroid hormones and age-adjusted
mortality as well as the potentially mediating role of cardiometabolic risk factors on the relationship between vitamin
D and all-cause mortality.
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